Compare CWK & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWK | NVST |
|---|---|---|
| Founded | 1784 | 2018 |
| Country | United States | United States |
| Employees | 53000 | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | 2018 | 2019 |
| Metric | CWK | NVST |
|---|---|---|
| Price | $12.53 | $25.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $17.64 | ★ $25.33 |
| AVG Volume (30 Days) | 1.5M | ★ 2.1M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | ★ 0.38 | 0.28 |
| Revenue | ★ $10,288,200,000.00 | $2,566,500,000.00 |
| Revenue This Year | $6.61 | $6.67 |
| Revenue Next Year | $6.32 | $3.55 |
| P/E Ratio | ★ $32.21 | $90.77 |
| Revenue Growth | ★ 8.91 | N/A |
| 52 Week Low | $7.82 | $14.22 |
| 52 Week High | $17.40 | $30.42 |
| Indicator | CWK | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 47.88 | 49.87 |
| Support Level | $11.61 | $19.29 |
| Resistance Level | $12.93 | $26.63 |
| Average True Range (ATR) | 0.52 | 0.96 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 67.55 | 74.59 |
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.